Drug Trial Radar · NCT03591068
Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video
Last checked: Nov 19, 2026Latest source record: Aug 3, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
11
Actual
Start
Jun 7, 2018
Primary completion
Feb 22, 2019
Study completion Feb 22, 2019
Sponsor
- Lead sponsor
- Optinose US Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 18, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 24-week, open-label, multi-center study designed to assess the efficacy and safety of OPN-375 186 μg twice a day in subjects with nasal polyps using Nasoendoscopic video. The total planned number of subjects is approximately 10, with each subject receiving OPN-375 186 μg twice a day.
Conditions
- Nasal Polyposis
Interventions
Fluticasone PropionateDrug
OPN-375 186 μg BID, Delivered via exhalation delivery system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Visit 1 at End of Study in Bilateral Nasal Polyp Grade Using Endoscopic VideoTime frame: Week 24
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of Colorado SOM, Department of Otolaryngology
Aurora, Colorado
University of Texas Health Science Center at Houston, McGovern Medical School, Dept. of Otolaryngology, Head and Neck Surgery
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.